The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure. The FDA has approved Hibsago (bepirovirsen), GSK’s antisense oligonucleotide, for adults with chronic hepatitis B who are already taking…
NASHVILLE — In this Healio video, Arun B. Jesudian, MD, discusses hepatitis B developments including new therapies for highly selective patients, updated treatment guidelines and different vaccination recommendations from the ACG Annual Meeting.“The hepatitis B space is changing and, particularly,…
Hepatitis C is an infectious disease transmitted through blood contaminated with the virus. Particular caution is needed in medical settings, where infection can occur if syringes are reused or... by Jang Ga Rin | by Source: Korea Medical Dispute Mediation and…
Hepatitis C is curable. But every year, nearly one million people still acquire the infection. People who inject drugs are among those most affected, often without access to the equipment and services that could help prevent it. As a major…
Since September of last year, a team of Danish researchers, backed by $1.6 million in funding from RFK Jr.’s CDC, had planned a large-scale hepatitis B vaccine trial in the sub-Saharan African nation of Guinea-Bissau. · Screening mothers for hepatitis B…
The FDA also authorized the Roche Elecsys HBsAg II quant II RxDx assay as a companion diagnostic device to aid in the selection of patients with chronic HBV infection for treatment with antiviral... FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment…
GSK’s bepirovirsen (Hibsago) has secured FDA approval for the treatment of chronic hepatitis B virus (HBV), when used with existing antiviral therapy in adults without cirrhosis. “This is the start of... Thank you for visiting nature.com. You are using…
Full results from the pivotal B-Well 1 and B-Well 2 phase 3 trials confirm that bepirovirsen delivers statistically significant functional cure rates in chronic hepatitis B. Bepirovirsen (GSK/Ionis...
FRIDAY, Oct. 23, 2026 (HealthDay News) — Some adults with chronic hepatitis B may now have a path to something today’s treatments rarely deliver — stopping all medication while the virus stays in check. The U.S. Food and Drug Administration on Tuesday approved…
Jordan Feld, MD, MPH, discusses bepirovirsen's approval and how capsid assembly modulators and gene editing could lead to a true hepatitis B cure. The FDA recently approved bepirovirsen (Hibsago; GSK), the first antisense oligonucleotide to treat chronic hepatitis B.1 “This is…
Viral hepatitis B, C and D: testing and screening, new treatments and cures, and national elimination goals.
An article joins this feed when it matches these terms. Each one is also a search of its own.